STAT
MARCH 12, 2024
Over the past year, I have watched many children die of measles. In the final stages, little lungs, filled with fluid and racked with inflammation, struggle for oxygen. The victims breathe faster and faster, gasping for air until, exhausted, they stop.
Fierce Healthcare
MARCH 12, 2024
ORLANDO — It's almost impossible to have a conversation at HIMSS24 without the topic of artificial intelligence or generative AI coming up. | How will the conversations about AI in healthcare change by next year's HIMSS conference? Hackensack Meridian CEO Robert Garrett predicts that pilot projects underway now will roll out into practice.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 12, 2024
DETROIT — Every morning, Rebecca Smith, nursing a surgically repaired knee, carefully walks down the hallway of her brutalist brick apartment building, takes the elevator one floor to the lobby, and negotiates the sharply angled driveway outside. There, she waits for an Uber to take her to the last place she wants to go: her methadone clinic.
Pharmacy Times
MARCH 12, 2024
This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MARCH 12, 2024
The implementation of targeted educational interventions might improve knowledge gaps, which pose great risk to patients, in type 2 diabetes (T2D) management.
STAT
MARCH 12, 2024
The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients compared to placebo hit the ALS patient community hard. An earlier study had shown that patients who took the drug for six months experienced significantly less decline than people on the placebo in physical function, such as the ability to speak, use utensils, or climb stairs.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 12, 2024
The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week. The pill, called resmetirom, is made by Madrigal Pharmaceuticals. Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH , is often associated with obesity.
Pharmacy Times
MARCH 12, 2024
The cream significantly reduced abscesses and inflammatory nodules, reaffirming its efficacy as a maintenance option for HS.
STAT
MARCH 12, 2024
WASHINGTON — In the last year, an estimated 11% of high school seniors have used Delta 8 THC, according to a new report published Tuesday in the Journal of the American Medical Association. Delta 8 THC is a quasi-legal psychoactive version of cannabis, which has skyrocketed in popularity after a loophole found in a 2018 federal law allowed it to be sold nationwide without the same restrictions placed on traditional marijuana.
pharmaphorum
MARCH 12, 2024
Discover why gut bacteria are considered the next frontier in medicine in this informative article. Learn about the importance of the microbiome, its impact on health, and how it relates to conditions like Clostridiales difficile.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
MARCH 12, 2024
Researchers at the University of California, Los Angeles have built a soft, adhesive patch capable of turning throat movements into speech. The patch, written about in a paper published in Nature Communications on Tuesday, is made out of a material that converts motion into electricity. This material, developed by the UCLA team in 2021, could be a gamechanger for sensors and wearables limited by their power sources.
Fierce Healthcare
MARCH 12, 2024
President Joe Biden's 2025 budget did not just touch upon cybersecurity, the drug price negotiation program and Medicare solvency, as the plan also suggested policy for mental health, health equity | Many significant policy items in Biden's proposed 2025 fiscal year budget don't grab the initial headlines, but he's looking to make strides in mental health, substance use disorder and maternal health.
Drug Topics
MARCH 12, 2024
N-3 polyunsaturated fatty acids (PUFAs) are essential nutrients, especially during pregnancy as they support neurodevelopment in offspring and improve pregnancy outcomes.
Fierce Healthcare
MARCH 12, 2024
The nation’s largest for-profit health systems reassured investors Tuesday that the Change Healthcare cyberattack, though disruptive in the short term, is a “transitory” event that’s unlikely to ha | Senior leadership at HCA Healthcare, Tenet Healthcare and Universal Health Systems say their organizations are shielded from the liquidity and administrative issues that are plaguing providers across the country.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
MARCH 12, 2024
Discover the latest agency, consultancy, and investor hires from February 2024, including personnel from OVID Health, Avalere, WE Communications, and Eurozeo. Stay updated with industry movements and key players.
Fierce Healthcare
MARCH 12, 2024
ORLANDO — CodaMetrix, a company that provides automated coding technology for healthcare billing and revenue cycle management, picked up $40 million in fresh funding to build out its AI-based | odaMetrix, a company that provides automated coding technology for healthcare billing and revenue cycle management, picked up $40 million in fresh funding to build out its AI-based soultions.
pharmaphorum
MARCH 12, 2024
In the latest episode of the pharmaphorum podcast, host Nicole Raleigh speaks (virtually) with Nathan Clark, founder and CEO of Ganymede, a modern data platform and Cloud infrastructure for science, to discuss the evolving role of the Cloud in biopharma and some rather revolutionary tools in AI drug discovery.
Pharmacy Times
MARCH 12, 2024
Individuals included in the study reported positive changes in fatigue, and disease activity displayed endoscopic and histologic remission.
Pharmaceutical Commerce
MARCH 12, 2024
A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians.
Fierce Pharma
MARCH 12, 2024
Despite Moderna’s efforts to prove its mRNA thesis beyond COVID-19 in 2023, the post-pandemic hangover took a toll on the company. | Despite Moderna’s efforts to prove its mRNA thesis beyond COVID-19 in 2023, the post-pandemic hangover took a heavy toll on the company. In turn, much of the company’s top brass—including CEO Stéphane Bancel—saw their total compensation fall for the year.
Pharmacy Times
MARCH 12, 2024
Although newly approved, there is some debate regarding the benefits and populations in which sotagliflozin will be the most effective.
Fierce Pharma
MARCH 12, 2024
The antibody-drug conjugate (ADC) Adcetris has given Pfizer’s oncology department its first pivotal trial win from the legacy Seagen portfolio since the $43 billion merger. | The antibody-drug conjugate Adcetris has given Pfizer’s oncology department its first pivotal trial win from the legacy Seagen portfolio since the $43 billion merger.
pharmaphorum
MARCH 12, 2024
Up to 25,000 patients in England with ulcerative colitis are eligible for treatment with Pfizer’s Velsipity after NICE backed use of the drug on the same day as its MHRA approval.
Fierce Pharma
MARCH 12, 2024
Acacia Pharmaceuticals is calling it quits on future testing of Nuplazid after a string of expansion efforts have come up short. | The company will not conduct any further clinical trials of the drug, which is currently approved to treat Parkinson’s disease psychosis. The decision comes after years of failed expansion bids in other uses.
Pharmacy Times
MARCH 12, 2024
Integrate nutrition into the health care system with a proactive approach to chronic disease management
Pharmaceutical Commerce
MARCH 12, 2024
A sit-down with Groovy Singh, CEO of Bright Green Corporation, who describes the waves in the global supply chain the company is making after being authorized to grow cannabis, along with cannabis-related products.
STAT
MARCH 12, 2024
Top of the morning to you, and a fine one it is. Sunny skies and a crisp breeze are wafting over the Pharmalot campus, where the official mascots are roaming about in search of noshes and amusement. This marks a welcome change from the unusual high winds the day before. So we have decided to celebrate by firing up the coffee kettle to brew another cup of stimulation.
pharmaphorum
MARCH 12, 2024
Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says an independent UK review.
STAT
MARCH 12, 2024
Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a larger crisis engulfing the entire industry. While Steward’s for-profit ownership structure put its hospitals at a disadvantage, many health care executives say the state’s entire network of hospitals is approaching a capacity shortage not seen since the early days of the Covid-19 pandemic.
Drug Topics
MARCH 12, 2024
In 2021, medical spending on pediatric mental health conditions accounted for 46.6% of all pediatric medical spending that year.
Pharmacy Times
MARCH 12, 2024
Health span, wealth span, advocacy, and ethics are all burgeoning topics within the field of longevity.
STAT
MARCH 12, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with news that STAT+, our exclusive source for trusted and authoritative coverage of the life sciences, is on sale this week. Claim your exclusive offer now and save 40% with code STAT40.
The Checkup by Singlecare
MARCH 12, 2024
If you are in the market for a pain medication like Advil , you’ve probably wondered: “Is Advil ibuprofen?” This is an understandable question. The difference between Advil and ibuprofen can feel confusing for lots of folks. Thankfully, the answer is simple. Ibuprofen is the active ingredient in Advil. In other words, Advil is a pain reliever with ibuprofen as its main ingredient.
Outsourcing Pharma
MARCH 12, 2024
International pharmaceutical firm Angelini Pharma has initiated a creative crowdsourcing campaign aimed at enhancing target identification in epilepsy, particularly focusing on drug-resistant phenotypes.
Expert insights. Personalized for you.
145 
Let's personalize your content